Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Publikationen des W. G. Kerckhoff-Instituts     Display Documents



ID: 559820.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Publikationen des W. G. Kerckhoff-Instituts
[Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]
Authors:Ghofrani, H. A.; Distler, O.; Gerhardt, F.; Gorenflo, M.; Grunig, E.; Haefeli, W. E.; Held, M.; Hoeper, M. M.; Kahler, C. M.; Kaemmerer, H.; Klose, H.; Kollner, V.; Kopp, B.; Mebus, S.; Meyer, A.; Miera, O.; Pittrow, D.; Riemekasten, G.; Rosenkranz, S.; Schranz, D.; Voswinckel, R.; Olschewski, H.
Title of Journal:Dtsch Med Wochenschr
Volume:135 Suppl 3
Start Page:S87
End Page:101
Audience:Not Specified
Abstract / Description:The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension have been adopted for Germany. The guidelines contain detailed recommendations for the treatment of pulmonary arterial hypertension (PAH). However, the practical implementation of the European Guidelines in Germany requires the consideration of several country-specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to the treatment of PAH. This commentary summarizes the results and recommendations of the working group on treatment of PAH.
Free Keywords:Algorithms; Anti-Arrhythmia Agents/therapeutic use; Anticoagulants/therapeutic use; Calcium Channel Blockers/therapeutic use; Combined Modality Therapy; Cooperative Behavior; Digoxin/therapeutic use; Drug Therapy, Combination; *Evidence-Based Medicine; Exercise Therapy; Female; Germany; Humans; Hypertension, Pulmonary/genetics/psychology/*rehabilitation; Interdisciplinary Communication; Oxygen Inhalation Therapy; *Patient Care Team; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors/therapeutic use; Pregnancy; Prostaglandins/therapeutic use; Receptors, Endothelin/antagonists & inhibitors; Vasodilator Agents/*therapeutic use
External Publication Status:published
Document Type:Article
Communicated by:N. N.
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:Abteilung Pneumologie, Medizinische Klink II, Universitatsklinikum Giessen und Marburg, Standort Giessen. ardeschir.ghofrani@innere.med.uni-giessen.de
Identifiers:ISSN:1439-4413 (Electronic) 0012-0472 (Linking)
URL:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=..
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.